BackTable Urology
Ep. 193 Bladder Cancer Innovations: ESMO 2024 Highlights with Dr. Andrea Apolo
Dr. Bogdana Schmidt
It's for the micrometastatic disease. It's to combat that. And so here the adjuvant stuff becomes really important because. PT zero, I don't know how meaningful of an endpoint it is long term. Right.
0
💬
0
Comments
Log in to comment.
There are no comments yet.